ABSTRACT
BACKGROUND: The olfactory loss in patients with chronic rhinosinusitis has been measured by different methods. However, the results have been variable and it is not clear whether functional endoscopic sinus surgery (FESS) significantly improves olfactory function. This study was performed to evaluate the influences of FESS on olfactory function in patients with chronic rhinosinusitis using three different types of olfactory tests. METHODS: Seventy patients with chronic rhinosinusitis were administered the University of Pennsylvania Smell Identification Test (UPSIT), a single staircase phenyl ethyl alcohol odor detection threshold test (STT), and a short-term odor memory/discrimination test a day before and 6 months after FESS. A questionnaire inquiring about the patients' self-perception of olfactory function was administered also. Independent ratings of the severity of chronic rhinosinusitis before FESS were established from CT scans. RESULTS: Fifty-two (74.3%) of the patients reported that their olfactory function was impaired before surgery, and 68.6% of the patients reported impaired olfactory function after surgery, a difference that was not significant. No meaningful changes in any of the olfactory test scores were noted 6 or more months after FESS. Preoperatively, small correlations between CT scores and the symptom scores (r = 0.278; p = 0.024), threshold scores (r = -0.27; p = 0.031), and UPSIT scores (r = -0.36; p = 0.003) were observed. CONCLUSION: In patients with severe rhinosinusitis, FESS had little impact on the ability to smell, regardless of the method for assessing smell function. Subtle associations between olfactory function and the severity of chronic rhinosinusitis determined by CT were observed, however, preoperatively. The olfactory test measures were correlated with one another both pre- and postoperatively.
Subject(s)
Endoscopy , Otorhinolaryngologic Surgical Procedures/methods , Rhinitis/physiopathology , Sinusitis/physiopathology , Smell/physiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Chronic Disease , Female , Follow-Up Studies , Humans , Male , Middle Aged , Rhinitis/complications , Rhinitis/surgery , Severity of Illness Index , Sinusitis/complications , Sinusitis/surgery , Surveys and Questionnaires , Treatment OutcomeABSTRACT
The indications for endoscopic sinus surgery (ESS) have been widely expanding since its introduction into sinus surgery. ESS has become an ideal method to manage certain orbital diseases and has the advantages of excellent visualization with minimal cosmetic and functional morbidity. In the Department of Otolaryngology of Taichung Veterans General Hospital from 1988 to 2005, 3,136 patients received ESS. Among them, a total of 108 patients received ESS for orbital diseases. These orbital diseases included orbital complications secondary to bacterial rhinosinusitis, fungal rhinosinusitis, skull base osteomyelitis and mucoceles, subperiosteal hematoma, Graves' disease, traumatic optic neuropathy and orbital blowout fracture. Our results showed that ESS is effective in the management of some of these orbital diseases.
Subject(s)
Endoscopy , Orbital Diseases/surgery , Paranasal Sinuses/surgery , Adolescent , Adult , Aged , Child , Child, Preschool , Cohort Studies , Female , Humans , Male , Middle Aged , Orbital Diseases/diagnosis , Orbital Diseases/etiology , Recovery of Function , Retrospective Studies , Taiwan , Treatment OutcomeABSTRACT
BACKGROUND: Fungus-driven inflammation is proposed to play an important role in the pathogenesis of chronic rhinosinusitis (CRS). Previous studies tested the efficacy of intranasal antifungal agents for patients with nasal polyps. The purpose of this study was to evaluate the efficacy of intranasal amphotericin B (AMB) in patients who have CRS without nasal polyps (CRSsNP). METHODS: Patients diagnosed with CRSsNP were enrolled in this study. They were assigned randomly to receive irrigation with AMB solution (20 mg of AMB in 500 mL of normal saline) or placebo (yellowish dye in 500 mL of normal saline) for 4 weeks. The outcome measures included the Chinese version of the Rhinosinusitis Outcome Measure 31 (CRSOM-31), nasal endoscopy, and bacterial and fungal cultures. RESULTS: Seventy patients were enrolled and 64 patients completed this study. There was significant improvement in the AMB group (n = 32) both in endoscopic (p = 0.013) and CRSOM-31 scores (p < 0.0001). The placebo group (n = 32) showed significant improvement in CRSOM-31 scores (p < 0.0001). CRSOM-31 scores were significantly lower in the AMB group than in the placebo group after 2-week treatment (p = 0.018) and remained lower after 4-week treatment, although the difference was not significant (p = 0.091). There were no significant differences in endoscopic scores and bacterial or fungal culture rates between two groups after treatment. CONCLUSION: Our results showed that AMB irrigation improved symptoms and endoscopic scores but did not show superiority to saline irrigation alone in patients who have CRSsNP.
